{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:47:36Z","timestamp":1778680056110,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.dsx.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T20:32:40Z","timestamp":1506025960000},"page":"189-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Platelet rich plasma and growth factors cocktails for diabetic foot ulcers treatment: State of art developments and future prospects"],"prefix":"10.1016","volume":"12","author":[{"given":"I.V.","family":"Gonchar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.R.","family":"Lipunov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.","family":"Afanasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Larina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.P.","family":"Faller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Kibardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2017.09.007_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-2840-11-18","article-title":"A retrospective analysis of amputation rates in diabetic patients: can lower extremity amputations be further prevented?","volume":"11","author":"Alvarsson","year":"2012","journal-title":"Cardiovasc Diabetol"},{"issue":"S1","key":"10.1016\/j.dsx.2017.09.007_bib0010","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/dmrr.833","article-title":"The diabetic foot: grand overview: epidemiology and pathogenesis","volume":"24","author":"Boulton","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"10.1016\/j.dsx.2017.09.007_bib0015","first-page":"1655","article-title":"Diabetic foot ulcers: pathogenesis and management","volume":"66","author":"Frykberg","year":"2002","journal-title":"Am Fam Phys"},{"issue":"9368","key":"10.1016\/j.dsx.2017.09.007_bib0020","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(03)13169-8","article-title":"Diabetic foot ulcers","volume":"361","author":"Jeffcoate","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1067-2516(07)60001-5","article-title":"Diabetic foot disorders: a clinical practice guideline (2006 revision)","volume":"45","author":"Frykberg","year":"2006","journal-title":"J foot Ankle Surg"},{"issue":"4","key":"10.1016\/j.dsx.2017.09.007_bib0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2337\/diacare.26.4.1069","article-title":"Predictive value of foot pressure assessment as part of a population-based diabetes disease management program","volume":"26","author":"Lavery","year":"2003","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2337\/diacare.24.3.483","article-title":"Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers","volume":"24","author":"Margolis","year":"2001","journal-title":"Diabetes Care"},{"issue":"S1","key":"10.1016\/j.dsx.2017.09.007_bib0040","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1002\/dmrr.848","article-title":"Practical guidelines on the management and prevention of the diabetic foot","volume":"24","author":"Apelqvist","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40257-014-0081-9","article-title":"Diabetic foot ulcer: an evidence-based treatment update","volume":"15","author":"Braun","year":"2014","journal-title":"Am J Clin Dermatol"},{"issue":"Suppl. 2","key":"10.1016\/j.dsx.2017.09.007_bib0050","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1086\/383266","article-title":"Foot problems in diabetes: an overview","volume":"39","author":"Ulbrecht","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.dsx.2017.09.007_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7547\/87507315-90-2-57","article-title":"The potential benefits of advanced therapeutic modalities in the treatment of diabetic foot wounds","volume":"90","author":"Hogge","year":"2000","journal-title":"J Am Podiatr Med Assoc"},{"issue":"4","key":"10.1016\/j.dsx.2017.09.007_bib0060","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1464-5491.2008.02414.x","article-title":"Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing","volume":"25","author":"Muller","year":"2008","journal-title":"Diabetic Med"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2006.00155.x","article-title":"Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers","volume":"14","author":"Galkowska","year":"2006","journal-title":"Wound Repair Regen"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0070","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2353\/ajpath.2006.050293","article-title":"Severely impaired insulin signaling in chronic wounds of diabetic ob\/ob mice: a potential role of tumor necrosis factor-\u03b1","volume":"168","author":"Goren","year":"2006","journal-title":"Am J Pathol"},{"issue":"9498","key":"10.1016\/j.dsx.2017.09.007_bib0075","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(05)67700-8","article-title":"Wound healing and its impairment in the diabetic foot","volume":"366","author":"Falanga","year":"2005","journal-title":"Lancet"},{"issue":"06","key":"10.1016\/j.dsx.2017.09.007_bib0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4236\/ss.2016.76038","article-title":"Role of platelet rich plasma in treatment of diabetic foot ulcers","volume":"7","author":"Salem","year":"2016","journal-title":"Surg Sci"},{"issue":"2","key":"10.1016\/j.dsx.2017.09.007_bib0085","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1172\/JCI114210","article-title":"Growth factors in wound healing: single and synergistic effects on partial thickness porcine skin wounds","volume":"84","author":"Lynch","year":"1989","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.dsx.2017.09.007_bib0090","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/diacare.26.6.1856","article-title":"Human epidermal growth factor enhances healing of diabetic foot ulcers","volume":"26","author":"Tsang","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.dsx.2017.09.007_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1534734615575829","article-title":"Effectiveness of platelet-rich plasma to enhance healing of diabetic foot ulcers in patients with concomitant peripheral arterial disease and critical limb ischemia","volume":"15","author":"Kontopodis","year":"2016","journal-title":"Int J Lower Extremity Wounds"},{"issue":"1","key":"10.1016\/j.dsx.2017.09.007_bib0100","first-page":"1","article-title":"Platelet-rich plasma: support for its use in wound healing","volume":"83","author":"Lacci","year":"2010","journal-title":"Yale J Biol Med"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/scrt218","article-title":"Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors","volume":"4","author":"Amable","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.dsx.2017.09.007_bib0110","series-title":"The diabetic foot","year":"2006"},{"issue":"2","key":"10.1016\/j.dsx.2017.09.007_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/bjs.4019","article-title":"Growth factors in the treatment of diabetic foot ulcers","volume":"90","author":"Bennett","year":"2003","journal-title":"British J Surg"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1172\/JCI32169","article-title":"Cellular and molecular basis of wound healing in diabetes","volume":"117","author":"Brem","year":"2007","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.dsx.2017.09.007_bib0125","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1089\/ten.2006.12.3067","article-title":"Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells","volume":"12","author":"Dolder","year":"2006","journal-title":"Tissue Eng"},{"issue":"21","key":"10.1016\/j.dsx.2017.09.007_bib0130","doi-asserted-by":"crossref","first-page":"7696","DOI":"10.1073\/pnas.84.21.7696","article-title":"Role of platelet-derived growth factor in wound healing: synergistic effects with other growth factors","volume":"84","author":"Lynch","year":"1987","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0135","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI118169","article-title":"Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds","volume":"96","author":"Pierce","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.dsx.2017.09.007_bib0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1524-475X.1997.50106.x","article-title":"The role of growth factors in the healing of chronic wounds","volume":"5","author":"Robson","year":"1997","journal-title":"Wound Repair Regener"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0145","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/wrr.12205","article-title":"Clinical application of growth factors and cytokines in wound healing","volume":"22","author":"Barrientos","year":"2014","journal-title":"Wound Repair Regen"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0150","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1530\/acta.0.1230326","article-title":"Epidermal growth factor and platelet-derived growth factor in blood in diabetes mellitus","volume":"123","author":"Lev-Ran","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000658-198609000-00011","article-title":"Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet-derived wound healing factors (PDWHF)","volume":"204","author":"Knighton","year":"1986","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.dsx.2017.09.007_bib0160","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers","volume":"56","author":"Hong","year":"2006","journal-title":"Ann Plast Surg"},{"issue":"11","key":"10.1016\/j.dsx.2017.09.007_bib0165","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2174\/1381612013397573","article-title":"Role of cytokines and cytokine therapy in wound healing and fibrotic diseases","volume":"7","author":"Gharaee-Kermani","year":"2001","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0170","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/(SICI)1096-9896(200004)190:5<589::AID-PATH553>3.0.CO;2-T","article-title":"Lack of insulin\u2010like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers","volume":"190","author":"Blakytny","year":"2000","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.dsx.2017.09.007_bib0180","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/archsurg.134.2.200","article-title":"Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing","volume":"134","author":"Corral","year":"1999","journal-title":"Arch Surg"},{"issue":"11","key":"10.1016\/j.dsx.2017.09.007_bib0185","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","article-title":"Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes","volume":"48","author":"Cooper","year":"1999","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.dsx.2017.09.007_bib0190","first-page":"505","article-title":"Vascular endothelial growth factor gene expression in patients' ischemic skeletal muscle with diabetic foot","volume":"36","author":"Wang","year":"2002","journal-title":"Zhonghua yu fang yi xue za zhi Chin J Preventive Med"},{"issue":"1","key":"10.1016\/j.dsx.2017.09.007_bib0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jcjd.2013.08.271","article-title":"Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report","volume":"38","author":"Mehrannia","year":"2014","journal-title":"Can J Diabetes"},{"issue":"S1","key":"10.1016\/j.dsx.2017.09.007_bib0200","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/dmrr.2707","article-title":"Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review","volume":"32","author":"Game","year":"2016","journal-title":"Diabetes\/metabolism Res Rev"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0205","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-0501.2003.00810.x","article-title":"Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank","volume":"14","author":"Weibrich","year":"2003","journal-title":"Clin Oral Implants Res"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-0501.2003.00810.x","article-title":"Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank","volume":"14","author":"Weibrich","year":"2003","journal-title":"Clin Oral Implants Res"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0215","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1034\/j.1600-0501.2002.130513.x","article-title":"Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes","volume":"13","author":"Gruber","year":"2002","journal-title":"Clin Oral Implants Res"},{"issue":"21","key":"10.1016\/j.dsx.2017.09.007_bib0220","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/j.biomaterials.2012.04.007","article-title":"Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation","volume":"33","author":"Murphy","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.dsx.2017.09.007_bib0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.csm.2008.08.007","article-title":"Treatment of tendon and muscle using platelet-rich plasma","volume":"28","author":"Mishra","year":"2009","journal-title":"Clin Sports Med"},{"key":"10.1016\/j.dsx.2017.09.007_bib0230","series-title":"Autologous platelet\u2010rich plasma for treating chronic wounds. The 47 Library","author":"Martinez\u2010Zapata","year":"2012"},{"issue":"7","key":"10.1016\/j.dsx.2017.09.007_bib0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.12968\/jowc.2016.25.7.393","article-title":"Platelet-rich plasma, bilayered acellular matrix grafting and negative pressure wound therapy in diabetic foot infection","volume":"25","author":"Deng","year":"2016","journal-title":"J Wound Care"},{"issue":"6","key":"10.1016\/j.dsx.2017.09.007_bib0240","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00000658-198812000-00019","article-title":"Acceleration of tensile strength of incisions treated with EGF and TGF-beta","volume":"208","author":"Brown","year":"1988","journal-title":"Annal surg"},{"issue":"1","key":"10.1016\/j.dsx.2017.09.007_bib0245","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0002-9610(05)80589-6","article-title":"Growth factors and wound healing: part II. Role in normal and chronic wound healing","volume":"166","author":"Bennett","year":"1993","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0250","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2337\/diacare.21.5.822","article-title":"Efficacy and safely of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study","volume":"21","author":"Wieman","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2017.09.007_bib0255","article-title":"Healing of diabetic foot ulcers using transforming growth factor\u2014beta in collagen sponge","author":"McPherson","year":"1999","journal-title":"Meeting f the European Tissue Repair Society"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0260","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1684\/ejd.2009.0750","article-title":"Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer","volume":"19","author":"Uchi","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1524-475x.2001.00347.x","article-title":"Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers","volume":"9","author":"Robson","year":"2001","journal-title":"Wound Repair Regen"},{"issue":"2","key":"10.1016\/j.dsx.2017.09.007_bib0270","article-title":"Healing of chronic venous ulcers is not enhanced by the addition of topical repifermin (KGF-2) to standardized care","volume":"4","author":"Robson","year":"2004","journal-title":"J Appl Res"},{"issue":"6","key":"10.1016\/j.dsx.2017.09.007_bib0275","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/hum.2006.17.683","article-title":"Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial","volume":"17","author":"Kusumanto","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.dsx.2017.09.007_bib0280","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40005-016-0268-6","article-title":"Pharmaceutical perspectives of impaired wound healing in diabetic foot ulcer?","volume":"46","author":"Lau","year":"2016","journal-title":"J Pharm Invest"},{"issue":"3","key":"10.1016\/j.dsx.2017.09.007_bib0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/term.1513","article-title":"Promotion of diabetic wound healing by collagen scaffold with collagen-binding vascular endothelial growth factor in a diabetic rat model","volume":"8","author":"Tan","year":"2014","journal-title":"J Tissue Eng Rgenerative Med"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117302941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402117302941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T02:54:05Z","timestamp":1602989645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402117302941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1871402117302941"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2017.09.007","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet rich plasma and growth factors cocktails for diabetic foot ulcers treatment: State of art developments and future prospects","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}